Supplementary Methods, Supplementary Table 1-4 and Supplementary Figure Legends from Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients with HER2-Negative Primary Breast Cancer
crossref（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined